UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 70

Sortiert nach

Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments

Health policy (Amsterdam), 2022-01, Vol.126 (1), p.49-59

2022

Link zum Volltext

Verfügbarkeit prüfen

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

Health policy (Amsterdam), 2012-11, Vol.108 (1), p.19-26

2012

Link zum Volltext

Verfügbarkeit prüfen

Diffusion of innovations: treatment of Alzheimer's disease in Germany

Health policy (Amsterdam), 2002-04, Vol.60 (1), p.59-66

2002

Link zum Volltext

Verfügbarkeit prüfen

The influence of economic evaluation studies on decision making.: A European survey

Health policy (Amsterdam), 2000-07, Vol.52 (3), p.179-192

Hoffmann, Christiane

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of cost and utilization of pharmaceuticals in Germany

Health policy (Amsterdam), 1997-09, Vol.41 (Supp.), p.S45-S53

von der Schulenburg, J.-Matthias Graf

1997

Link zum Volltext

Verfügbarkeit prüfen

The influence of economic evaluation studies on decision making. A European survey. The EUROMET group

Health policy (Amsterdam), 2000-07, Vol.52 (3), p.179

2000

Link zum Volltext

Verfügbarkeit prüfen

Management of cost and utilization of pharmaceuticals in Germany

Health policy (Amsterdam), 1997, Vol.41 (1), p.45-53

von der Schulenburg, J. -Matthias Graf

1997

Link zum Volltext

Verfügbarkeit prüfen

Cross-national perspectives on pharmaceutical and home care policy

Health policy (Amsterdam), 1997-09, Vol.41 (Supp.), p.1-174

1997

Link zum Volltext

Verfügbarkeit prüfen

Socio-economic burden of rare diseases: A systematic review of cost of illness evidence

Health policy (Amsterdam), 2015-07, Vol.119 (7), p.964-979

2015

Link zum Volltext

Verfügbarkeit prüfen

Effects of pay for performance in health care: A systematic review of systematic reviews

Health policy (Amsterdam), 2013-05, Vol.110 (2), p.115-130

2013

Link zum Volltext

Verfügbarkeit prüfen

How did European countries set health priorities in response to the COVID-19 threat? A comparative document analysis of 24 pandemic preparedness plans across the EURO region

Health policy (Amsterdam), 2024-03, Vol.141, p.104998-104998, Article 104998

2024

Link zum Volltext

Verfügbarkeit prüfen

Oral health status and coverage of oral health care: A five-country comparison

Health policy (Amsterdam), 2023-11, Vol.137, p.104913-104913, Article 104913

2023

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain

Health policy (Amsterdam), 2023-12, Vol.138, p.104919-104919, Article 104919

2023

Link zum Volltext

Verfügbarkeit prüfen

A critical review of methodologies used in pharmaceutical pricing policy analyses

Health policy (Amsterdam), 2023-08, Vol.134, p.104576-104576, Article 104576

2023

Link zum Volltext

Verfügbarkeit prüfen

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review

Health policy (Amsterdam), 2019-12, Vol.123 (12), p.1185-1198

2019

Link zum Volltext

Verfügbarkeit prüfen

A systematic review of the use of economic evaluation in local decision-making

Health policy (Amsterdam), 2008-05, Vol.86 (2), p.129-141

2008

Link zum Volltext

Verfügbarkeit prüfen

Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea

Health policy (Amsterdam), 2016-08, Vol.120 (8), p.867-874

2016

Link zum Volltext

Verfügbarkeit prüfen

Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe

Health policy (Amsterdam), 2021-12, Vol.125 (12), p.1550-1556

2021

Link zum Volltext

Verfügbarkeit prüfen

Disease management and health care reforms in Germany—Does more competition lead to less solidarity?

Health policy (Amsterdam), 2007-01, Vol.80 (1), p.86-96

2007

Link zum Volltext

Verfügbarkeit prüfen

Promoting innovation while controlling cost: The UK's approach to health technology assessment

Health policy (Amsterdam), 2022-03, Vol.126 (3), p.224-233

2022

Link zum Volltext

Verfügbarkeit prüfen

Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence

Health policy (Amsterdam), 2022-04, Vol.126 (4), p.337-345

2022

Link zum Volltext

Verfügbarkeit prüfen

Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review

Health policy (Amsterdam), 2022-12, Vol.126 (12), p.1248-1255

2022

Link zum Volltext

Verfügbarkeit prüfen

Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?

Health policy (Amsterdam), 2020-09, Vol.124 (9), p.943-951

2020

Link zum Volltext

Verfügbarkeit prüfen

Developing a composite index of spatial accessibility across different health care sectors: A German example

Health policy (Amsterdam), 2016-02, Vol.120 (2), p.205-212

2016

Link zum Volltext

Verfügbarkeit prüfen

Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland

Health policy (Amsterdam), 2020-06, Vol.124 (6), p.639-646

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 70

Suche als RSS-Feed

Aktive Filter

SprachePortugiesisch

KollektionIngentaConnect

Zeitschrift / SerieHealth Policy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(70)

Sprache

Englisch
(70)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(70)
Ingenta E-Journals
(70)
Elsevier ScienceDirect Journals Complete
(70)
MEDLINE
(58)
IngentaConnect Journals
(26)
Applied Social Sciences Index & Abstracts (ASSIA)
(25)
PAIS Index
(23)

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Amortization of gene replacement therapies: A health policy analysis exploring a mechanism for mitigating budget impact of high-cost treatments

Delphi approach to select rare diseases for a European representative survey. The BURQOL-RD study

Diffusion of innovations: treatment of Alzheimer's disease in Germany

The influence of economic evaluation studies on decision making.: A European survey

Management of cost and utilization of pharmaceuticals in Germany

The influence of economic evaluation studies on decision making. A European survey. The EUROMET group

Management of cost and utilization of pharmaceuticals in Germany

Cross-national perspectives on pharmaceutical and home care policy

Socio-economic burden of rare diseases: A systematic review of cost of illness evidence

Effects of pay for performance in health care: A systematic review of systematic reviews

How did European countries set health priorities in response to the COVID-19 threat? A comparative document analysis of 24 pandemic preparedness plans across the EURO region

Oral health status and coverage of oral health care: A five-country comparison

A systematic review of policies regulating or removing mark-ups in the pharmaceutical supply and distribution chain

A critical review of methodologies used in pharmaceutical pricing policy analyses

Barriers and facilitators of patient access to medical devices in Europe: A systematic literature review

A systematic review of the use of economic evaluation in local decision-making

Factors influencing the difference between forecasted and actual drug sales volumes under the price–volume agreement in South Korea

Variation in market access decisions for cell and gene therapies across the United States, Canada, and Europe

Disease management and health care reforms in Germany—Does more competition lead to less solidarity?

Promoting innovation while controlling cost: The UK's approach to health technology assessment

Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence

Barriers for the evaluation of advanced therapy medicines and their translation to clinical practice: Umbrella review

Review of Relative effectiveness assessments (REAs) of pharmaceuticals at the European network for health technology assessment (EUnetHTA): A first step towards a consolidated European perspective on comparative effectiveness & safety?

Developing a composite index of spatial accessibility across different health care sectors: A German example

Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland

Aktive Filter

Suchergebnisse filtern